Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Jul '25 Jul 31, 2025	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	May '21 May 25, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	2014 - 2018
Market Capitalization	0	4	16	15	5	23	Upgrade
Market Cap Growth	-73.52%	-76.02%	3.01%	177.29%	-76.52%	-24.29%	Upgrade
Enterprise Value	-	12	19	19	8	25	Upgrade
Last Close Price	0.00	0.07	0.52	0.56	0.84	6.80	Upgrade
PS Ratio	0.00	0.80	3.95	-	1.26	5.36	Upgrade
PB Ratio	0.00	-1.27	3.29	49.03	-0.60	1.60	Upgrade
P/TBV Ratio	-	-	-	49.03	-	1.60	Upgrade
P/OCF Ratio	-	-	-	37.97	-	-	Upgrade
EV/Sales Ratio	-	2.53	4.85	-	1.91	5.66	Upgrade
Debt / Equity Ratio	-2.87	-3.03	1.71	4.97	-0.38	0.09	Upgrade
Asset Turnover	0.28	0.26	0.35	-	0.34	0.36	Upgrade
Inventory Turnover	3.13	4.26	3.63	-	4.48	5.85	Upgrade
Quick Ratio	0.01	0.01	0.37	0.01	0.05	0.04	Upgrade
Current Ratio	0.08	0.08	0.47	0.01	0.16	0.47	Upgrade
Return on Equity (ROE)	-	-1297.71%	-	-	-777.47%	-545.28%	Upgrade
Return on Assets (ROA)	-19.29%	-20.44%	-24.32%	-	-60.78%	-26.88%	Upgrade
Return on Capital (ROIC)	-38.09%	-39.17%	-76.80%	-	-148.77%	-74.77%	Upgrade
Earnings Yield	-11770483.33%	-294.04%	-37.74%	-0.62%	-388.13%	-52.23%	Upgrade
FCF Yield	-2740896.97%	-127.21%	-24.32%	-12.81%	-38.51%	-11.42%	Upgrade
Buyback Yield / Dilution	-68.47%	-145.80%	-	-	-89.16%	-105.12%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.